Manuscripts
November 2, 2020
Improving Cancer Data Interoperability: The Promise of the mCODE (Minimal Common Oncology Data Elements) Initiative
JCO Clinical Cancer Informatics
Osterman T et al
Abstracts
June 3, 2022
Machine learning modeling of real-world primary resistance and hyperprogression in immune checkpoint inhibitor (ICI) treated advanced non-small cell lung cancer (aNSCLC) patients
ASCO Annual Meeting 2022
Das R et al
June 3, 2022
Evaluating the impact of performance status criteria on minority eligibility for oncology clinical trials
ASCO Annual Meeting 2022
Bhandari S et al
June 3, 2022
Identifying genetic factors of response and resistance to CDK4/6 inhibitors in metastatic HR+/HER2- breast cancer using real-world data
ASCO Annual Meeting 2022
Agrawal S et al
June 3, 2022
Impact of trial site selection on minority patient recruitment in prostate cancer trials
ASCO Annual Meeting 2022
Lagor C et al
June 3, 2022
Characterizing node-negative non-small cell lung cancer patients with similarity networks: A CancerLinQ Discovery analysis
ASCO Annual Meeting 2022
Moen EL et al
June 3, 2022
Diagnosed with advanced prostate cancer: A population-based cohort from national oncology practices
ASCO Annual Meeting 2022
Kim SP et al
June 3, 2022
The survival benefit of anti-HER2 treatment in the management of small (T1mic, T1a, T1b, T1c), node-negative HER2+ breast cancer
ASCO Annual Meeting 2022
Johnson K et al
June 3, 2022
Molecular testing and patterns of treatment in NSCLC patients: An IASLC analysis of ASCO CancerLinQ Discovery data
ASCO Annual Meeting 2022
Behera M et al
June 3, 2022
Associations between biomarker testing and characteristics of patients with metastatic non-small cell lung cancer (mNSCLC): an analysis of CancerLinQ Discovery (CLQD) data
ASCO Annual Meeting 2022
Mileham KF et al
